C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2002
11/21/2002	WO2002092056A1 Compaction process for manufacture of sodium phenytoin dosage form
11/21/2002	WO2002091989A2 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
11/21/2002	US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002	US20020173530 Single morphic forms of metalloproteinase inhibitors
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002	CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	CA2446957A1 Compaction process for manufacture of sodium phenytoin dosage form
11/21/2002	CA2445459A1 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same
11/20/2002	EP1258479A2 Process for the production of N,N-carbonyl diimidazole
11/20/2002	EP1258250A1 Nerve protective drugs
11/20/2002	EP1257519A1 Chemical transformation of substrates using nonmetallic, organic catalyst compositions
11/20/2002	EP1165472A4 Methods for the preparation of biphenyl isoxazole sulfonamides
11/20/2002	EP1042301B1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
11/20/2002	EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use
11/20/2002	EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/20/2002	CN1094491C 2-{4-[4-(4,5-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and use thereof
11/20/2002	CN1094488C Polymerizable urea/ureido functional monomers
11/19/2002	US6482954 Imidazole containing compounds having relatively low hydrogen content and relatively high nitrogen content and polymers and copolymers formed therefrom
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002	US6482844 1-benzylimidazole derivatives
11/19/2002	US6482827 Matrix metalloproteinase inhibitors
11/15/2002	WO2001096294A1 Method for the production of caprolactam
11/15/2002	CA2409357A1 Method for the production of caprolactam
11/14/2002	WO2002090350A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090335A1 Azole compounds, process for preparation of the same and use thereof
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	WO2002081453A8 Thiohydantoins and use thereof for treating diabetes
11/14/2002	WO2002062324A3 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/14/2002	US20020169329 Ester Compounds, methods of controlling a pest and uses of the ester compounds
11/14/2002	US20020169326 Fatty acid derivatives
11/14/2002	US20020169194 Treating vision defects
11/14/2002	US20020169193 Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence
11/14/2002	US20020169177 Imidazole and benzimidazole caspase inhibitors and uses thereof
11/14/2002	US20020169161 Bicyclic sulfanimde compounds useful for the treatment of cardiac arrhythmias
11/14/2002	US20020168761 Cell adhesion modulator for use in the treatment of nervous system disorders
11/14/2002	CA2446387A1 Azole compound, process for producing the same and use thereof
11/14/2002	CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1256571A1 Process for the preparation of D,L-methionine or a salt thereof
11/13/2002	EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002	EP1255737A1 Process for preparing a 1-substituted 5-hydroxymethyl imidazole
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP0956379B1 Use of 1-amidoalkylimidazoles for inhibiting corrosion
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/12/2002	US6479700 Method for separating a basic amino acid from fermentation broth
11/12/2002	US6479666 Phenyl-keto-imidazolidine thioamide derivatives
11/12/2002	US6479659 Improved process and novel intermediates to endothelin receptor antagonists
11/12/2002	US6479608 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
11/12/2002	US6479554 Immunotherapeutic agents
11/12/2002	US6479550 α-sulfenimino acid derivatives
11/12/2002	US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002	US6479530 Substituted 4(5)-(1-indanyl,-indanylmethyl, indanylmethylen), 4(5)-(1-(1,2,3,4-tetrahydronaphthyl, -naphthylmethyl and naphthylmethylen)imidazoles; hypotensive, ischemic and anxiolytic agents; nervous and muscular system disorders
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002	US6478827 Use of cationic monobenzene nitroanilines in the dyeing of keratinous fibers, dyeing compositions and dyeing processes
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002	WO2002088068A1 Aminoacid-iodine complex
11/07/2002	WO2002087619A1 Preventive/therapeutic method for cancer
11/07/2002	WO2002087571A1 Aromatase inhibitors as novel veterinary drugs
11/07/2002	WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002	WO2002056827A3 Substituted felbamate derived compounds
11/07/2002	WO2002044141A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
11/07/2002	US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002	US20020165393 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
11/07/2002	US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/07/2002	US20020165165 Free radical scavengers; also use as an amphiphilic lipid to form lipid vesicles; N-octyloxycarbonyl-beta-alanyl-L-histidine, for example
11/07/2002	US20020165095 Herbicidally active benzoylcyclohexanediones
11/07/2002	US20020164549 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms
11/07/2002	CA2445294A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1254092A1 Resolution of dl-racemic mixtures
11/06/2002	EP1254075A1 Nonaborate compositions and their preparation
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	CN1378536A Neutral-cationic lipid for nuelci acid and drug delivery
11/06/2002	CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476234 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002	WO2002086508A2 Elisa kit for the determination of cyp2c19 metabolic phenotypes and uses thereof
10/31/2002	WO2002085864A1 Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085863A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085862A1 Imidazolidine derivatives as chemokine receptor modulators
10/31/2002	WO2002085861A1 Imidazolidine compounds and their use as cxcr3 antagonists
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative

1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 345